🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to assess changes in vascular permeability in the brain tum...
Status
Completed
Location
University of Michigan Hospital
Start Date
2005-04
Trial ID
NCT02031237
The main purpose of this study is to see whether addition of TPI 287 to FSR...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2014-10-09
Trial ID
NCT02187822
Treatments Being Tested
For non-small cell lung cancer brain metastases, stereotactic radiotherapy ...
Status
Recruiting
Location
Sun yat-sen University Cancer Center
Start Date
2025-06-30
Trial ID
NCT07058428
Treatments Being Tested
This phase III trial compares post-surgical surveillance to post-surgical r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01-28
Trial ID
NCT07785687
Brain metastasis is the most challenging disease in the field of tumor trea...
Status
Recruiting
Location
Ruijin Hospital
Start Date
2024-03-15
Trial ID
NCT06231186
Treatments Being Tested
Brain metastases occur in 30-50% of patients with metastatic HER2-positive ...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2020-01-02
Trial ID
NCT04582968
Treatments Being Tested
There is a lack of prospective trial data and consensus guidelines describi...
Status
Recruiting
Location
Montefiore Medical Center
Start Date
2017-12-25
Trial ID
NCT03726359
Treatments Being Tested
This Phase II randomized study is to determine the efficacy and safety of B...
Status
Completed
Location
Sun Yat-sen University
Start Date
2020-01-01
Trial ID
NCT04345146
Treatments Being Tested
Brain metastasis accounted for 10-15% of all breast cancer patients and eve...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-07-01
Trial ID
NCT04061408
Treatments Being Tested
This is a research study to find out if the new anti-cancer drug Durvalumab...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT04889066
Treatments Being Tested